Fibrinogen and the prediction of residual obstruction manifested after pulmonary embolism treatment

Benjamin Planquette, Olivier Sanchez, James J. Marsh, Peter G. Chiles, Joseph Emmerich, Grégoire Le Gal, Guy Meyer, Tanya Wolfson, Anthony C. Gamst, Roger E. Moore, Gabriel B. Gugiu, Timothy A. Morris

Source: Eur Respir J, 52 (5) 1801467; 10.1183/13993003.01467-2018
Journal Issue: November
Disease area: Pulmonary vascular diseases

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Benjamin Planquette, Olivier Sanchez, James J. Marsh, Peter G. Chiles, Joseph Emmerich, Grégoire Le Gal, Guy Meyer, Tanya Wolfson, Anthony C. Gamst, Roger E. Moore, Gabriel B. Gugiu, Timothy A. Morris. Fibrinogen and the prediction of residual obstruction manifested after pulmonary embolism treatment. Eur Respir J, 52 (5) 1801467; 10.1183/13993003.01467-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Impact of residual pulmonary obstruction on the long-term outcome of patients with pulmonary embolism
Source: Eur Respir J, 49 (5) 1601980; 10.1183/13993003.01980-2016
Year: 2017




Persistent lung perfusion defect is a risk factor for recurrent venous thromboembolism after pulmonary embolism
Source: Annual Congress 2012 - Pulmonary circulation: clinical aspects of PAH, PTE and CTEPH
Year: 2012


Pulmonary embolism severity index and D-dimer for risk-stratification of patients with acute pulmonary embolism
Source: Annual Congress 2010 - Pulmonary venous thromboembolic disease and other pulmonary vascular disorders
Year: 2010

Prognostic value of the ECG on admission in patients with acute major pulmonary embolism
Source: Eur Respir J 2005; 25: 843-848
Year: 2005



Pulmonary embolism and the consequences for the right heart
Source: ISSN=ISSN 1025-448x, ISBN=ISBN 1-904097-42-1, page=136
Year: 2006

PP312 – Diagnosis of non severe pulmonary embolism
Source: ERS Lung Science Conference 2021
Year: 2021

Persisting symptoms after pulmonary embolism
Source: International Congress 2016 – ME5 Persisting symptoms after pulmonary embolism
Year: 2016

Predicting recurrent pulmonary embolism and chronic thromboembolic pulmonary hypertension: one more way to skin the cat
Source: Eur Respir J, 49 (5) 1700413; 10.1183/13993003.00413-2017
Year: 2017



Does a bronchial obstruction influence a diagnostic approach in patient with pulmonary embolism?
Source: Eur Respir J 2004; 24: Suppl. 48, 275s
Year: 2004

Treatment of acute pulmonary embolism
Source: School Course 2014 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2014



Treatment of acute pulmonary embolism
Source: ERS Skills course - Pulmonary hypertension and pulmonary vascular disease
Year: 2018

Treatment of acute pulmonary embolism
Source: ERS Course 2020 - Pulmonary hypertension and pulmonary vascular disease
Year: 2020

Treatment of acute pulmonary embolism
Source: ERS Course 2017 - Pulmonary Hypertension and Pulmonary Vascular Disease
Year: 2017

The shock index and the simplified PESI for identification of low-risk patients with acute pulmonary embolism
Source: Eur Respir J 2011; 37: 762-766
Year: 2011



The assessment of lung function and residual hypoxemia after balloon pulmonary angioplasty for patients with non-operable chronic thromboembolic hypertension
Source: Virtual Congress 2020 – Chronic thromboembolic pulmonary hypertension
Year: 2020


Increased incidence of pulmonary embolism in severe asthma
Source: Annual Congress 2011 - Asthma management and response
Year: 2011


Evaluation of our patient with pulmonary embolism
Source: Eur Respir J 2006; 28: Suppl. 50, 45s
Year: 2006

Different diagnosis of unilateral absence of pulmonary perfusion mimicking pulmonary embolism
Source: Eur Respir J 2001; 18: Suppl. 33, 226s
Year: 2001